Connect with us

Health

Colorectal cancer is now leading cause of death among young adults with cancer: new report

Published

on

Colorectal cancer is now leading cause of death among young adults with cancer: new report

Read this article for free!

Plus get unlimited access to thousands of articles, videos and more with your free account!

Please enter a valid email address.

By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

Colorectal cancer is now among the leading causes of cancer deaths for young adults, according to a new report from the American Cancer Society (ACS).

Each year, the ACS compiles data on the numbers of new cancer cases and deaths in the U.S., which are published in CA: A Cancer Journal for Clinicians.

Advertisement

Colorectal cancer has steadily grown among adults younger than 50, the report noted.

CANCER CAUSES: THESE 10 HIDDEN CARCINOGENS CAN RAISE THE RISK, ACCORDING TO AN ONCOLOGY EXPERT

In the late 1990s, it was the fourth-leading cause of cancer death in that age group. 

As of 2024, it ranks as the leading cause of cancer deaths in men and the second leading cause in women.

Colorectal cancer is now among the leading causes of cancer deaths for young adults, according to a report from the American Cancer Society (ACS). (iStock)

Advertisement

Dr. Aparna Parikh, medical director of the Center for Young Adult Colorectal Cancer at the Mass General Cancer Center, who is not affiliated with the ACS, said she is “alarmed but not surprised” by the rising colorectal rates among young people — and particularly by the fact that colon cancer is now the leading cause of cancer death for men under 50. 

The colorectal cancer research community has been working to determine why rates are rising among young adults, Parikh said.

PATIENTS WITH METASTATIC COLORECTAL CANCER COULD FIND HOPE IN NEW FDA-APPROVED TREATMENT

“We don’t entirely understand why yet, but it seems to be an interplay of a person’s risk factors, overall makeup and early exposures,” she told Fox News Digital in an email.

“The exposures include dietary exposures, environmental exposures and possible antibiotic exposures, as well as lifestyle factors in the right host,” Parikh added. 

Advertisement

“Screening at [age] 45 is [the] standard of care, and the gold standard is colonoscopy.”

There are many people who have healthy lifestyle habits and no apparent risk factors who go on to develop colorectal cancer, the doctor noted — “and then there are plenty of patients who have less than ideal habits.”

She said, “It really is an interplay between the right person and the right exposures.”

As of 2024, colorectal cancer ranks as the leading cause of cancer deaths in men. (iStock)

Some primary risk factors include family history, obesity, smoking, heavy alcohol, a diet high in red and processed meats, inflammatory bowel disease and a personal history or family history of polyps, according to Parikh.

Advertisement

To reduce cases in younger patients, the doctor stressed the importance of raising public awareness of the disease around recognizing symptoms early.

CANCER RISK COULD INCREASE WITH CONSUMPTION OF CERTAIN FOODS AND DRINKS, STUDY FINDS

She also recommended certain healthy lifestyle habits, including avoiding or limiting red meat, not smoking, exercising regularly and adopting a more Mediterranean-based diet. 

Early screening is also important, Parikh noted.

“Screening at [age] 45 is [the] standard of care, and the gold standard is colonoscopy — but there are also stool-based tests that are appropriate,” she said. 

Advertisement

“If you are having any symptoms like weight loss, blood in stool, anemia or change in bowel habits, you should go straight to colonoscopy.”

Some primary risk factors for colorectal cancer include family history, obesity, smoking, heavy alcohol, a diet high in red and processed meats, inflammatory bowel disease and a personal history or family history of polyps, according to a cancer doctor. (iStock)

Overall, the ACS expects that over 2 million new cancer cases and 611,720 cancer deaths will occur in the U.S. in 2024.

Although overall cancer mortality has been dropping — likely as a result of earlier detection, improved treatments and healthy lifestyle behaviors — the report stated that several types of cancers have increased in prevalence.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

In addition to colorectal cancer, cervical cancer also rose 1% to 2% annually among adults between 30 and 44 years of age.

Among all age groups, cancer rates rose 0.6% to 1% annually for breast, pancreas and uterine corpus cancers, and 2% to 3% annually for prostate, liver (female), kidney and human papillomavirus-associated oral cancers and for melanoma, the report stated.

The data in the ACS report was drawn from central cancer registries and mortality data collected by the National Center for Health Statistics.

Fox News Digital reached out to the ACS for additional comment.

Advertisement

For more Health articles, visit foxnews.com/health

Health

Goodbye, Late-Night Cravings! How To Curb Hunger and Make Weight Loss Easier

Published

on

Goodbye, Late-Night Cravings! How To Curb Hunger and Make Weight Loss Easier


Advertisement





How To Curb Late-Night Cravings and Make Weight Loss Easier | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Lurking dementia risk exposed by breakthrough test 25 years before symptoms

Published

on

Lurking dementia risk exposed by breakthrough test 25 years before symptoms

NEWYou can now listen to Fox News articles!

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge.

Advertisement

That’s according to new research from the University of California San Diego, which found that a specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk.

The researchers analyzed blood samples from 2,766 participants in the Women’s Health Initiative Memory Study in the late 1990s, according to the study’s press release. 

KEY FITNESS MEASURE IS STRONG PREDICTOR OF LONGEVITY AFTER CERTAIN AGE, STUDY FINDS

The women ranged from 65 to 79 years of age and showed no signs of cognitive decline at the start of the study.

After tracking the participants for up to 25 years, the researchers concluded that the biomarker phosphorylated tau 217 (p-tau217) was “strongly associated” with future mild cognitive impairment and dementia. 

Advertisement

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. (iStock)

Women who had higher levels of p-tau217 at the beginning of the study were “much more likely” to develop the disease. The findings were published today in JAMA Network Open.

“The key takeaway is that our study suggests it may be possible to detect risk of dementia two decades in advance using a simple blood test in older women,” first author Aladdin H. Shadyab, a UC San Diego associate professor of public health and medicine, told Fox News Digital. 

“These biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia.”

“Our findings show that the blood biomarker p-tau217 could help identify individuals at higher risk for dementia long before symptoms begin,” he added.

Advertisement

This long lead time could open the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life, according to Shadyab.

A specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk. (iStock)

“As the research advances, these biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia,” he said.

This risk relationship wasn’t the same across the board, however. Women over 70 with higher p-tau217 levels had “poorer cognitive outcomes” compared to those under 70, as did those with the APOE ε4 gene, which is a known risk factor for Alzheimer’s disease.

Advertisement

The study also found that p-tau217 was a stronger predictor of dementia in women who were randomly assigned to receive estrogen and progestin hormone therapy compared to those who received a placebo.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” said senior author Linda K. McEvoy, senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health, in the release. 

“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” a researcher said. (iStock)

“This is important for accelerating research into the factors that affect the risk of dementia and for evaluating strategies that may reduce risk.”

Advertisement

Blood tests for Alzheimer’s disease are still being studied and are not recommended for routine screening in people without symptoms, Shadyab noted. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

More research is needed before this approach can be considered for clinical use prior to cognitive symptoms. 

Future studies should investigate how other factors — like genetics, hormone therapy and age-related medical conditions — might interact with plasma p-tau217, the researchers added.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

“The study examined only older women, so the findings may not necessarily apply to men or younger populations,” Shadyab noted. “We also examined overall dementia outcomes rather than specific subtypes such as Alzheimer’s disease.”

Continue Reading

Health

Key fitness measure is strong predictor of longevity after certain age, study finds

Published

on

Key fitness measure is strong predictor of longevity after certain age, study finds

NEWYou can now listen to Fox News articles!

For women over 60, muscle strength plays a critical role in longevity, a new study confirms.

Researchers at the University at Buffalo, New York, followed more than 5,000 women between the ages of 63 and 99, finding that those with greater muscle strength had a significantly lower risk of death over an eight-year period.

The findings were published in JAMA Network Open.

EXERCISE AFFECTS THE HEART IN A HIDDEN, POWERFUL WAY BY REWIRING NERVES, STUDY FINDS

Advertisement

Muscle function was measured using grip strength and how quickly participants could complete five unassisted sit-to-stand chair raises. 

These are two tests commonly used in clinical settings to evaluate muscle function in older adults, the researchers noted.

A recent study shows that stronger muscle strength in women over 60 is linked to a lower risk of death over eight years. (iStock)

“In a community cohort of ambulatory older women, muscular strength was associated with significantly lower mortality rates, even when we accounted for usual physical activity and sedentary time measured using a wearable monitor, gait speed and blood C-reactive protein levels,” study lead author Michael LaMonte, research professor of epidemiology and environmental health at the University at Buffalo, told Fox News Digital.

“Movement is the key — just move more and sit less.”

Advertisement

Many earlier studies did not include those objective measurements, making it difficult to determine whether muscle strength itself was linked to longevity, according to LaMonte. “Our study was able to better isolate the association between strength and death in later life,” he added.

Even for women who don’t get the recommended amount of aerobic physical activity, which is at least 150 minutes per week, muscle strength remained important for longevity, the researchers found.

Women with greater muscle strength were more likely to live longer, even if they did not meet the recommended amount of aerobic exercise. (iStock)

“The findings of lower mortality in those who had higher strength but were not meeting current national guidelines on aerobic activity were somewhat intriguing,” LaMonte said.

Advertisement

CLICK HERE FOR MORE LIFESTYLE STORIES

Federal guidelines recommend strengthening activities one to two days per week, targeting major muscle groups.

Resistance training does not have to require a gym membership, LaMonte noted. These exercises can be performed using free weights, resistance bands, bodyweight movements or even household items, such as soup cans.

Experts recommend working major muscle groups one or two days a week using weights, bands or bodyweight exercises. (iStock)

“Movement is the key — just move more and sit less,” he said. “When we can no longer get out of the chair and move around, we are in trouble.”

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

LaMonte acknowledged several limitations of the study. The researchers assessed muscle strength in older age but did not explore how earlier levels in adulthood might influence long-term health outcomes.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“We were not able to understand how strength and mortality relate in younger ages,” he said, noting that future research should explore whether building strength earlier could have an even greater impact on longevity.

Advertisement
Continue Reading

Trending